CN Stock MarketDetailed Quotes

Hubei Jumpcan Pharmaceutical (600566)

Watchlist

26.25
+0.38+1.47%

Post Market Jul 16 15:00 CST

24.20BMarket Cap13.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Jumpcan Pharmaceutical (600566) Cash Flow

Quarterly·All

YOY

Hide blank lines

Currency: CNY

2026/Q1

2025/FY

2025/Q9

2025/H1

2025/Q1

2024/FY

2024/Q9

2024/H1

2024/Q1

2023/FY

2023/Q9

2023/H1

2023/Q1

2022/FY

2022/Q9

2022/H1

2022/Q1

2021/FY

2021/Q9

2021/H1

Operating Cash Flow

+10.89%880.34M

-44.94%1.20B

-59.56%703.51M

-37.95%972.47M

-40.70%793.90M

-37.17%2.18B

-39.17%1.74B

-28.71%1.57B

+2.86%1.34B

+32.17%3.46B

+41.42%2.86B

+50.03%2.20B

+29.38%1.30B

+38.35%2.62B

+26.76%2.02B

+19.61%1.47B

+38.11%1.01B

+6.32%1.89B

+11.74%1.60B

+3.84%1.23B

Cash Inflow from Operating Activities

-6.93%2.50B

-30.49%6.76B

-31.79%5.28B

-31.45%3.99B

-27.62%2.68B

-13.25%9.72B

-10.87%7.74B

-6.35%5.82B

+9.12%3.71B

+14.39%11.21B

+18.33%8.68B

+21.10%6.21B

+16.22%3.40B

+12.88%9.80B

+11.97%7.34B

+15.24%5.13B

+25.05%2.92B

+21.80%8.68B

+20.97%6.55B

+11.36%4.45B

Goods Sale Service Render Cash

-6.99%2.43B

-28.50%6.64B

-29.36%5.11B

-28.41%3.85B

-23.78%2.61B

-14.48%9.29B

-11.66%7.24B

-8.49%5.38B

+5.07%3.43B

+14.99%10.86B

+21.32%8.19B

+26.19%5.88B

+24.14%3.26B

+11.09%9.44B

+8.74%6.75B

+11.49%4.66B

+20.90%2.63B

+22.01%8.50B

+23.14%6.21B

+12.01%4.18B

Refunds of Taxes and Levies

----

+73.62%3.30M

+15.61%2.19M

+59.92%2.19M

----

-8.95%1.90M

--1.90M

--1.37M

Cash Received Relating to Other Operating Activities

-4.52%67.83M

-73.02%117.54M

-67.00%165.22M

-68.97%135.36M

-74.62%71.04M

+24.87%435.64M

+2.32%500.62M

+31.71%436.20M

+106.41%279.96M

-0.77%348.88M

-15.98%489.25M

-29.12%331.19M

-54.15%135.63M

+97.28%351.58M

+70.86%582.27M

+73.13%467.22M

+81.35%295.82M

+13.10%178.21M

-8.82%340.80M

+1.74%269.87M

Cash Outflow from Operating Activities

-14.42%1.62B

-26.33%5.56B

-23.75%4.58B

-29.06%3.02B

-20.23%1.89B

-2.55%7.54B

+3.02%6.00B

+5.89%4.25B

+13.00%2.37B

+7.89%7.74B

+9.54%5.82B

+9.53%4.02B

+9.31%2.10B

+5.76%7.18B

+7.21%5.32B

+13.58%3.67B

+19.13%1.92B

+26.97%6.78B

+24.27%4.96B

+14.51%3.23B

Goods Services Cash Paid

-50.60%167.95M

-37.24%1.00B

-18.51%1.04B

-33.60%561.22M

-18.03%339.97M

+21.99%1.59B

+30.90%1.28B

+35.55%845.18M

+26.42%414.73M

+7.53%1.31B

+2.50%977.20M

+6.51%623.51M

+16.85%328.06M

+19.70%1.21B

+32.55%953.36M

+45.50%585.38M

+33.87%280.76M

+19.15%1.01B

+15.08%719.22M

-2.14%402.32M

Staff Behalf Paid

-6.24%275.88M

-14.69%801.10M

-15.11%635.21M

-14.64%463.97M

-5.51%294.25M

+8.15%939.02M

+10.16%748.29M

+12.38%543.54M

+5.84%311.41M

+6.03%868.29M

+5.10%679.29M

-0.39%483.68M

-4.12%294.22M

-11.16%818.94M

-8.26%646.32M

-0.69%485.57M

+5.40%306.85M

+11.78%921.86M

+12.67%704.54M

+6.93%488.97M

All Taxes Paid

-9.43%338.31M

-25.77%1.09B

-30.48%765.96M

-32.22%551.35M

-26.18%373.52M

-11.27%1.46B

-5.14%1.10B

-5.32%813.47M

+5.14%506.02M

+30.16%1.65B

+34.68%1.16B

+48.20%859.15M

+64.25%481.29M

+7.57%1.27B

+0.34%862.46M

-0.87%579.73M

-5.64%293.03M

+26.94%1.18B

+32.42%859.55M

+15.79%584.79M

Cash Paid Relating to Other Operating Activities

-5.30%834.27M

-24.74%2.67B

-25.74%2.13B

-29.75%1.44B

-22.41%880.95M

-9.43%3.55B

-4.50%2.87B

+0.04%2.05B

+14.51%1.14B

+1.11%3.92B

+5.31%3.01B

+1.68%2.05B

-4.30%991.53M

+5.58%3.87B

+6.68%2.85B

+15.06%2.02B

+29.92%1.04B

+33.98%3.67B

+27.95%2.68B

+21.19%1.75B

Net Cash Flows from Investing Activities

-27636.06%-2.55B

+52.14%-976.25M

+72.90%-562.77M

+52.52%-976.04M

-100.55%-9.20M

-417.45%-2.04B

-610.81%-2.08B

-248.68%-2.06B

+23.13%1.66B

+73.78%-394.23M

+118.05%406.53M

+163.84%1.38B

+169.46%1.35B

-123.28%-1.50B

-1793.92%-2.25B

-3995.67%-2.17B

-5195.13%-1.95B

+54.54%-673.30M

+49.94%-118.93M

+63.93%-52.88M

Cash Inflows from Investing Activities

+61.33%1.48B

+11.61%5.71B

+62.40%4.46B

+32.79%3.27B

-56.68%917.85M

+7.93%5.12B

-32.05%2.75B

-8.56%2.46B

+50.70%2.12B

-3.62%4.74B

+29.21%4.04B

+102.19%2.69B

+2442017.33%1.41B

+11.80%4.92B

-1.94%3.13B

-33.56%1.33B

-99.99%57.58K

+513.39%4.40B

+575.79%3.19B

+440.03%2.00B

Cash Received from Disposal of Investments

+63.66%1.45B

+9.71%5.52B

+58.54%4.30B

+28.31%3.13B

-57.73%889.00M

+8.18%5.03B

-31.45%2.71B

-7.21%2.44B

+53.40%2.10B

-3.08%4.65B

+30.40%3.96B

+106.51%2.63B

--1.37B

+10.32%4.80B

-3.78%3.04B

-35.71%1.28B

----

+546.66%4.35B

+578.32%3.15B

+443.32%1.98B

Cash Received from Returns on Investments

-10.29%25.86M

+124.78%190.64M

+394.22%157.18M

+682.27%131.96M

+82.26%28.82M

+3.27%84.81M

-57.83%31.80M

-66.56%16.87M

-44.03%15.81M

+21.60%82.12M

+76.89%75.41M

+206.28%50.44M

--28.25M

+37.50%67.53M

+24.51%42.63M

-15.37%16.47M

----

+546.10%49.11M

+499.36%34.24M

+313.93%19.46M

Net Cash Received from Disposal of Fixed Assets, Intangible Assets, and Other Long-Term Assets

-98.02%600.00

-10.89%619.08K

-82.49%129.45K

+33.02%110.57K

--30.24K

-91.29%694.76K

-90.37%739.12K

-98.78%83.12K

----

-84.89%7.98M

-84.56%7.68M

-82.56%6.81M

+11723.65%6.81M

+6551.57%52.82M

+6779.10%49.72M

+64049.24%39.02M

+30.85%57.58K

-48.44%794.08K

-39.96%722.83K

-94.66%60.83K

Cash Outflows from Investing Activities

+334.89%4.03B

-6.55%6.69B

+4.13%5.02B

-6.04%4.24B

+103.59%927.05M

+39.35%7.16B

+32.69%4.82B

+245.32%4.52B

+728.18%455.35M

-20.03%5.14B

-32.45%3.63B

-62.60%1.31B

-97.17%54.98M

+26.59%6.42B

+62.63%5.38B

+70.08%3.50B

+136.81%1.95B

+130.82%5.08B

+366.26%3.31B

+297.26%2.06B

Cash Paid to Acquire Fixed Assets, Intangible Assets, and Other Long-Term Assets

+658.07%193.68M

-45.01%95.86M

-50.12%71.95M

-62.07%40.82M

-70.41%25.55M

-42.21%174.34M

-39.44%144.22M

-16.33%107.64M

+57.05%86.35M

+23.80%301.64M

+32.47%238.16M

+5.35%128.65M

-52.27%54.98M

-1.88%243.66M

-3.86%179.79M

-9.56%122.12M

+44.15%115.20M

-42.20%248.32M

-44.84%187.00M

-39.43%135.03M

Cash Paid to Acquire Investments

+325.73%3.84B

-5.59%6.59B

+5.81%4.95B

-4.67%4.20B

+144.31%901.50M

+44.44%6.99B

+37.75%4.68B

+273.88%4.41B

--369.00M

-21.76%4.84B

-34.69%3.40B

-65.06%1.18B

----

+28.05%6.18B

+66.61%5.20B

+75.68%3.37B

+146.80%1.83B

+172.84%4.83B

+742.39%3.12B

+552.12%1.92B

Financing Cash Flow

+511.12%160.13M

-20.51%-1.45B

-91.40%-1.68B

-148.19%-1.92B

-105.98%-38.95M

-699.75%-1.21B

-114.59%-877.83M

-394.25%-773.35M

+17321.61%651.75M

-28.16%-150.69M

+19.53%-409.08M

+74.15%-156.47M

-237.15%-3.78M

+67.45%-117.58M

-45.21%-508.37M

-51.31%-605.18M

-3696.86%-1.12M

-196.63%-361.19M

-191.57%-350.09M

+59.86%-399.96M

Cash Inflows from Financing Activities

+193.63%832.82M

+0.98%1.46B

-34.16%763.66M

-42.99%449.11M

-57.50%283.63M

+29.92%1.44B

+91.23%1.16B

+118.12%787.82M

--667.38M

+123.19%1.11B

+524.07%606.50M

--361.19M

----

+894.37%497.18M

+94.37%97.18M

----

-96.44%50.00M

----

Cash Received from Capital Contributions

--6.60M

--20.24M

-82.52%2.50M

----

+379.47%14.31M

+45.47%14.31M

----

-85.38%14.21M

-96.93%2.98M

--9.83M

----

+94.37%97.18M

----

-96.44%50.00M

----

Cash from Borrowing

+191.30%826.23M

-0.42%1.44B

-33.55%761.16M

-42.26%446.61M

-57.50%283.63M

+31.61%1.44B

+89.80%1.15B

+120.15%773.51M

--667.38M

+173.86%1.10B

--603.51M

--351.36M

----

--400.00M

----

Cash Outflows from Financing Activities

+108.54%672.70M

+9.87%2.91B

+19.94%2.44B

+51.71%2.37B

+1963.45%322.58M

+110.01%2.65B

+100.64%2.04B

+201.58%1.56B

+313.09%15.63M

+105.01%1.26B

+67.71%1.02B

-14.46%517.66M

+237.15%3.78M

+49.51%614.77M

+51.35%605.55M

+51.31%605.18M

+3696.86%1.12M

-60.13%411.19M

-60.88%400.09M

-59.86%399.96M

Borrowing Repayment

+101.65%640.10M

-32.74%945.34M

-38.39%495.02M

+21.23%425.93M

--317.44M

+251.39%1.41B

+298.04%803.51M

+75.68%351.36M

----

+5219.32%400.00M

--201.87M

--200.00M

----

+884889.91%7.52M

----

+392.55%849.70

--39.60K

Dividend Interest Payment

+104.13%7.31M

+58.38%1.93B

+58.29%1.92B

+59.64%1.91B

-57.07%3.58M

+47.92%1.22B

+48.96%1.21B

+277.98%1.20B

+120.46%8.34M

+35.96%823.19M

+34.41%813.15M

-47.54%317.28M

+237.15%3.78M

+47.90%605.45M

+51.23%604.99M

+51.24%604.82M

+3696.86%1.12M

-59.42%409.37M

-60.10%400.05M

-59.87%399.92M

Cash Paid Relating to Other Financing Activities

+1519.35%25.28M

+44.82%34.15M

+38.23%31.51M

+166.14%28.05M

-78.58%1.56M

-36.51%23.58M

+4002.33%22.80M

+2704.98%10.54M

--7.29M

+1972.57%37.14M

+0.00%555.76K

+2.78%375.76K

----

-1.37%1.79M

--555.76K

--365.60K

----

-91.89%1.82M

----

Ending Cash Balance

-47.02%3.93B

-18.45%5.44B

-21.36%5.13B

-26.71%4.75B

-34.91%7.42B

-13.81%6.67B

-15.02%6.52B

-21.44%6.48B

+52.55%11.39B

+60.57%7.74B

+149.20%7.68B

+227.96%8.24B

+159.41%7.47B

+26.18%4.82B

-24.60%3.08B

-32.64%2.51B

-21.15%2.88B

+29.06%3.82B

+5.91%4.09B

+60.73%3.73B

Net Change in Cash

-302.54%-1.51B

-15.12%-1.23B

-26.71%-1.54B

-52.41%-1.92B

-79.59%745.76M

-136.61%-1.07B

-142.52%-1.21B

-136.84%-1.26B

+37.95%3.65B

+191.92%2.92B

+486.77%2.86B

+362.34%3.42B

+381.71%2.65B

+16.29%999.94M

-165.60%-738.70M

-269.02%-1.31B

-235.94%-940.26M

+27.51%859.84M

-28.38%1.13B

+1998.33%772.35M

Beginning Cash Balance

-18.45%5.44B

-13.81%6.67B

+60.57%7.74B

+26.18%4.82B

+29.06%3.82B

+29.51%2.96B

Effects of Exchange Rate Change on Cash

---10.37K

---9.94K

----

--103.35

----

Deadline

Mar 31, 2026

Dec 31, 2025

Sep 30, 2025

Jun 30, 2025

Mar 31, 2025

Dec 31, 2024

Sep 30, 2024

Jun 30, 2024

Mar 31, 2024

Dec 31, 2023

Sep 30, 2023

Jun 30, 2023

Mar 31, 2023

Dec 31, 2022

Sep 30, 2022

Jun 30, 2022

Mar 31, 2022

Dec 31, 2021

Sep 30, 2021

Jun 30, 2021

Accounting Standard

CAS (2007)

	2026/Q1	2025/FY	2025/Q9	2025/H1	2025/Q1	2024/FY	2024/Q9	2024/H1	2024/Q1	2023/FY	2023/Q9	2023/H1	2023/Q1	2022/FY	2022/Q9	2022/H1	2022/Q1	2021/FY	2021/Q9	2021/H1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.